Matches in Wikidata for { <http://www.wikidata.org/entity/Q37304715> ?p ?o ?g. }
- Q37304715 description "2011 മെയ് 1 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം" @default.
- Q37304715 description "article científic" @default.
- Q37304715 description "article scientifique" @default.
- Q37304715 description "articolo scientifico" @default.
- Q37304715 description "artigo científico" @default.
- Q37304715 description "artículu científicu espublizáu en 2011" @default.
- Q37304715 description "bilimsel makale" @default.
- Q37304715 description "scientific article published on May 2011" @default.
- Q37304715 description "vedecký článok" @default.
- Q37304715 description "vetenskaplig artikel" @default.
- Q37304715 description "videnskabelig artikel" @default.
- Q37304715 description "vědecký článek" @default.
- Q37304715 description "wetenschappelijk artikel" @default.
- Q37304715 description "wissenschaftlicher Artikel" @default.
- Q37304715 description "наукова стаття, опублікована в травні 2011" @default.
- Q37304715 description "научни чланак" @default.
- Q37304715 description "مقالة علمية نشرت في مايو 2011" @default.
- Q37304715 name "Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C" @default.
- Q37304715 name "Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C" @default.
- Q37304715 name "Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C." @default.
- Q37304715 type Item @default.
- Q37304715 label "Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C" @default.
- Q37304715 label "Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C" @default.
- Q37304715 label "Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C." @default.
- Q37304715 prefLabel "Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C" @default.
- Q37304715 prefLabel "Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C" @default.
- Q37304715 prefLabel "Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C." @default.
- Q37304715 P1433 Q37304715-D254CED9-197F-4CEA-AE03-4D6F1D7EE149 @default.
- Q37304715 P1476 Q37304715-EBCD4893-DFE3-48DC-99B7-5628A97C4940 @default.
- Q37304715 P2093 Q37304715-1509C5A1-FD29-4BA4-8E2F-80E98AF1110D @default.
- Q37304715 P2093 Q37304715-3C6CBCCF-0360-431D-8492-517A37545565 @default.
- Q37304715 P2093 Q37304715-4EB6C069-223D-4510-BA34-72389C5C2926 @default.
- Q37304715 P2093 Q37304715-53082268-7EB1-4E86-A391-4D6E50FF4429 @default.
- Q37304715 P2093 Q37304715-69990CA2-4001-4BDE-AE84-EE9D208E1A2C @default.
- Q37304715 P2093 Q37304715-7DE48360-4FC6-486B-884E-CD8C908B7C2C @default.
- Q37304715 P2093 Q37304715-AC2832C4-C2B8-4723-AFDD-C4B11396E8DD @default.
- Q37304715 P2093 Q37304715-BC20D2B8-021A-4CF5-9DF8-A42162B31D41 @default.
- Q37304715 P2093 Q37304715-BCC60D4F-EDE4-4271-B73D-1593304275A0 @default.
- Q37304715 P2093 Q37304715-BE7C35BD-8206-43D3-B476-E47D98532A78 @default.
- Q37304715 P2093 Q37304715-D2B03DFA-D8AF-4E13-846A-938319C26E55 @default.
- Q37304715 P2093 Q37304715-E310FE35-D9AE-4B63-B445-8A598BAC68B8 @default.
- Q37304715 P2093 Q37304715-EF81C723-8514-480B-91D6-C0B086B4CF83 @default.
- Q37304715 P2860 Q37304715-01349259-5D38-42D4-817E-0DA6B515DEDD @default.
- Q37304715 P2860 Q37304715-11FE0729-9D43-4BBE-8A4A-8A1093CB1C87 @default.
- Q37304715 P2860 Q37304715-1D1AB711-3886-4012-B924-48A5CF1D5628 @default.
- Q37304715 P2860 Q37304715-25F71488-A8BD-45F0-AFA7-360A61C2BAAE @default.
- Q37304715 P2860 Q37304715-28EB50F4-E1B5-437E-8644-C1C2DB629349 @default.
- Q37304715 P2860 Q37304715-34165486-593E-49FC-B836-422C2295638C @default.
- Q37304715 P2860 Q37304715-47EBCEE0-DB63-4B2E-A7ED-A1F60A61879A @default.
- Q37304715 P2860 Q37304715-4A6E937B-AE57-4145-B736-3169C68A72A1 @default.
- Q37304715 P2860 Q37304715-5047F4BB-688D-4D22-AC8A-FDA3DE7182D4 @default.
- Q37304715 P2860 Q37304715-53E0D8C9-E428-44AF-B97F-83BDFB058586 @default.
- Q37304715 P2860 Q37304715-60BB7337-8453-48C5-9A57-6D97CCA4876F @default.
- Q37304715 P2860 Q37304715-6C94B720-9F50-43DB-884D-88C53ACD3DB4 @default.
- Q37304715 P2860 Q37304715-7FA19068-9CBE-4E0E-9BE3-BE6C06A9C751 @default.
- Q37304715 P2860 Q37304715-87B7A4D7-0608-4A9B-BDF0-45CA5787AE25 @default.
- Q37304715 P2860 Q37304715-9280BAD4-1365-48D1-ADB0-62DA423D9C5B @default.
- Q37304715 P2860 Q37304715-986D471B-71B4-463A-A6B9-B5EB9078B276 @default.
- Q37304715 P2860 Q37304715-A2A0BDDE-47E3-4AAC-A97A-53C0A3604778 @default.
- Q37304715 P2860 Q37304715-A3E1D318-9A1A-46EB-BC9A-0F1546718B58 @default.
- Q37304715 P2860 Q37304715-B157B067-D391-4AD8-8FBA-3CC10F06A195 @default.
- Q37304715 P2860 Q37304715-BE0C509C-8A63-4139-AE5D-91B91426455A @default.
- Q37304715 P2860 Q37304715-BEACFA91-A041-4A1A-BAC1-C418C1748EE1 @default.
- Q37304715 P2860 Q37304715-C95EE777-BD88-4956-B284-C56134C2AD15 @default.
- Q37304715 P2860 Q37304715-CB992821-E29D-450F-BBE2-CF72D5A6D6E3 @default.
- Q37304715 P2860 Q37304715-D0BE530C-2A38-45C8-9E39-CC97B64C102B @default.
- Q37304715 P2860 Q37304715-DCCB6315-B821-4F3C-A83A-EA907EE7533C @default.
- Q37304715 P2860 Q37304715-E62D666B-42F1-47B1-BF27-358692AECCB6 @default.
- Q37304715 P2860 Q37304715-F904371D-3D51-422C-A7AE-CF56DDD5253C @default.
- Q37304715 P2860 Q37304715-F9B7AFFB-BE27-48A5-9B80-4746E3F6067D @default.
- Q37304715 P2860 Q37304715-FC282E1F-17CA-4ECE-9298-E880513B1355 @default.
- Q37304715 P2860 Q37304715-FD5F1499-AB58-4BA3-8E26-34FF12EF8FCE @default.
- Q37304715 P304 Q37304715-223C5987-D4DE-4561-A261-EC5BCEDD36CC @default.
- Q37304715 P31 Q37304715-E2C99D5E-9114-4301-8A81-C7E59320EFA1 @default.
- Q37304715 P356 Q37304715-BFE56EC8-4920-4991-8DA7-8B8172966786 @default.
- Q37304715 P433 Q37304715-A0C9C1F5-DD68-4409-844E-859FCB52B46D @default.
- Q37304715 P478 Q37304715-9B220063-FE7F-4F10-A6B5-D03A32E4C483 @default.
- Q37304715 P50 Q37304715-2E63F8DA-8010-4704-A0DD-1902B8B02766 @default.
- Q37304715 P577 Q37304715-AD3607D0-1C80-4E6C-86C6-F9C25EC344EE @default.
- Q37304715 P698 Q37304715-E75DFBD5-339B-4386-B5D7-737DDE6D4727 @default.
- Q37304715 P921 Q37304715-1CEE0348-F387-4D10-AC7D-1F9305558C81 @default.
- Q37304715 P921 Q37304715-43FC0BF6-47D1-4650-8B02-7CE7CA950730 @default.
- Q37304715 P921 Q37304715-C92C6834-85DD-4F6E-A52F-82FAFD2205BE @default.
- Q37304715 P932 Q37304715-D7A3725D-400B-45A3-8B28-EB8ABC1E637C @default.
- Q37304715 P356 J.1365-2893.2010.01310.X @default.
- Q37304715 P698 20367801 @default.
- Q37304715 P1433 Q15749962 @default.
- Q37304715 P1476 "Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C" @default.
- Q37304715 P2093 "A Conrad" @default.
- Q37304715 P2093 "A Zekry" @default.
- Q37304715 P2093 "C Cates" @default.
- Q37304715 P2093 "C Kenedi" @default.
- Q37304715 P2093 "G Qiang" @default.
- Q37304715 P2093 "H L Tillmann" @default.
- Q37304715 P2093 "J Albrecht" @default.
- Q37304715 P2093 "J G McHutchison" @default.
- Q37304715 P2093 "J George" @default.
- Q37304715 P2093 "K Brown" @default.
- Q37304715 P2093 "K Patel" @default.
- Q37304715 P2093 "L Elliott" @default.